Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Gastro-enteropancreatic neuroendocrine tumor × Leucovorin × 30 days × Clear all

Sponsor

Conditions

Colorectal Neoplasms 17 Stomach Neoplasms 10 Esophageal Neoplasms 7 Burkitt Lymphoma 7 Adenocarcinoma Of Esophagus 7 Pancreatic Neoplasms 6 Neoplasm Metastasis 6 Colonic Neoplasms 6 Carcinoma, Non-Small-Cell Lung 6 Rectal Neoplasms 5 Neoplasms 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Parkinson Disease 4, Autosomal Dominant Lewy Body 3 Ovarian Neoplasms 3 Lung Neoplasms 3 Leukemia, Biphenotypic, Acute 3 Cholangiocarcinoma 3 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 2 Endometrial Neoplasms 2 Colorectal Adenocarcinoma 2 Carcinoma, Pancreatic Ductal 2 Adenocarcinoma 2 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Small Cell Lung Carcinoma 1 Sarcoma, Ewing 1 Sarcoma 1

Interventions

pasireotide 1 E-7386 1 11-(2-methylpropyl)-12,13-dihydro-2-methyl-8-(pyrimidin-2-ylamino)-4H-indazolo(5,4-a)pyrrolo(3,4-c)carbazol-4-one 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡